Last checked at 28 Jul 2021 14:51
Hutchmed research costs deepen loss; expects US launches in 2022, 2023
Hutchmed research costs deepen loss; expects US launches in 2022, 2023
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News10
AZN Share
Chat7
AZN Share
Trades43,670
AZN
Live RNS1
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,034.00
Bid:
12,032.00
Ask:
12,036.00
Change:
682.00 (6.01%)
Spread:
4.00 (0.033%)
Open:
11,890.00
High:
12,096.00
Low:
11,790.00
Prev. Close:
11,352.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.28 Jul 2021 12:20
UPDATE 2-Raab calls for global vaccine drive as UK starts donating shots
(Adds Raab interview, adds media identifier COVAX)By Andrew MacAskillOXFORD, England, July 28 (Reuters) - British Foreign Secretary Dominic Raab warned that the world would not be adequately vaccinated until 2024 unless other countries joined Brit...
Read more28 Jul 2021 12:20
UPDATE 1-UK starts donating 9 million COVID-19 vaccines overseas
(Adds details, Foreign Secretary quote)LONDON, July 28 (Reuters) - Britain will start delivering 9 million doses of Oxford-AstraZeneca COVID-19 vaccine this week to countries including Indonesia, Jamaica and Kenya to help tackle the pandemic, the ...
Read more28 Jul 2021 11:33
IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial
IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial
Read more28 Jul 2021 10:58
AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%
AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%
Read more28 Jul 2021 07:53
UPDATE 2-AstraZeneca finds small clot risk after 1st COVID shot, less after 2nd
* Study finds TTS rate 8.1 per million after 1st dose* Study finds TTS rate 2.3 per million after 2nd dose* Results back 2nd dose, unless TTS after 1st - company (Writes through with detail)By Pushkala AripakaJuly 28 (Reuters) - AstraZeneca's COVID-...
Read more27 Jul 2021 15:19
IMF calls for rapid action to increase access to Covid-19 vaccines
(Sharecast News) - The International Monetary Fund's chief economist called on world governments to improve low-and-middle income countries' access to vaccines in order to avoid downside risks.
Read more27 Jul 2021 12:56
AstraZeneca partners with Regeneron to research obesity treatment
AstraZeneca partners with Regeneron to research obesity treatment
Read more27 Jul 2021 09:19
EU says it is on track for 70% vaccination target by end summer
BRUSSELS, July 27 (Reuters) - The European Union is on course to hit a target of fully vaccinating at least 70% of the adult population by the end of summer given that percentage of those 18 and over have now received a first dose, the European C...
Read more26 Jul 2021 21:09
UPDATE 1-Russia approves trials of combined AstraZeneca/Sputnik V vaccine
(Adds comments from Russian Direct Investment Fund)MOSCOW, July 26 (Reuters) - Russia has given the green light for clinical trials combining a British shot from AstraZeneca Plc and Oxford University with Russia's Sputnik V vaccine to go ahead, ac...
Read more26 Jul 2021 19:52
Russia approves trials of combined AstraZeneca/Sputnik V vaccine
MOSCOW, July 26 (Reuters) - Russia has given the green light for clinical trials combining a British shot from AstraZeneca and Oxford University with Russia's Sputnik V vaccine to go ahead, according to Russia's state drug register. The health mi...
Read more26 Jul 2021 18:45
COVID SCIENCE-People with allergic reaction to mRNA vaccines can get 2nd dose; Delta variant may be 1,000 times more infectious
By Nancy LapidJuly 26 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.Most with allergy to first mRNA shot can get second doseMost peo...
Read more26 Jul 2021 10:39
India to miss end-July vaccination target as Bharat Biotech lags
* Govt wants to inoculate all adults by year's end* Bharat Biotech has struggled to ramp up outputBy Krishna N. DasNEW DELHI, July 26 (Reuters) - India will miss a target to administer over a half billion COVID-19 vaccine doses by the end of the mo...
Read more26 Jul 2021 08:59
AstraZeneca drug Ultomiris recommended in EU for rare blood disorder
AstraZeneca drug Ultomiris recommended in EU for rare blood disorder
Read more26 Jul 2021 08:55
Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - study
By Sangmi ChaSEOUL, July 26 (Reuters) - A mixed vaccination of first AstraZeneca and then a Pfizer COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed.The study invol...
Read more